Related Experiment Videos
Human uroplakin lb gene structure and promoter analysis
Jonathon Olsburgh1, Robert Weeks, Peter Selby
1ICRF Cancer Research Centre, Leeds, UK.
Biochimica Et Biophysica Acta
|May 29, 2002
Summary
The uroplakin Ib (UPIb) gene promoter shows strong activity in urothelial cells, with higher activity in cancer cells. This finding offers potential for targeted gene therapy in bladder cancer treatment.
Area of Science:
- Urothelial biology
- Cancer genetics
- Molecular oncology
Background:
- The uroplakin Ib (UPIb) gene is primarily found in urothelium.
- UPIb is overexpressed in approximately 50% of transitional cell carcinoma (TCC) cases.
- Understanding UPIb gene regulation is crucial for TCC research.
Purpose of the Study:
- To identify and characterize the functional promoter of the human uroplakin Ib (UPIb) gene.
- To investigate the transcriptional activity of the UPIb promoter in normal and malignant urothelial cells.
- To explore the potential of the UPIb promoter in developing targeted gene therapy for bladder cancer.
Main Methods:
- Molecular cloning of the UPIb gene's 5' genomic region.
- Identification of transcription start sites using 5'RACE and ribonuclease protection assay (RPA).
- In vitro reporter gene assays with UPIb promoter fragments in urothelial cell lines.
Main Results:
- The human UPIb gene spans 31 kb and contains eight exons.
- Multiple transcription start sites were identified within exon 1.
- A 235-bp 5' UPIb fragment exhibited strong promoter activity in both normal and malignant urothelial cells.
- Malignant cell lines demonstrated significantly higher transcriptional activity compared to normal cells.
Conclusions:
- A functional promoter for the human UPIb gene has been identified.
- The UPIb promoter exhibits differential activity in normal versus malignant urothelial cells.
- The characterized UPIb promoter holds promise for targeted gene therapy strategies in bladder cancer.